Citriodiol in insect repellent may protect against COVID-19: UK study


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Citriodiol in insect repellent may protect against COVID-19: UK study
Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface

Citriodiol, an ingredient found in insect repellant, may kill novel coronavirus, according to British researchers. The ingredient extrapolated from the eucalyptus citriodora tree was studied for its use as a protective layer against SARS-CoV-2 by the UK’s military, according to a release by the Ministry of Defense.

The team of researchers out of the UK’s Defence Science and Technology Laboratory (Dstl) investigated the antiviral properties of Citriodiol against coronavirus by using a mosquito repellant, Mosi-guard, which contains Citriodiol as an active ingredient, the release stated. The insect repellant was applied to a liquid drop of the virus and then to a synthetic skin made of latex.

Citriodiol, an ingredient found in insect repellant, may kill the novel coronavirus, according to British researchers. (iStock)“One minute liquid suspension tests indicated that Mosi-guard Natural has anti-viral activity against SARS-CoV-2  isolate if mixed with the virus in the liquid phase. Additionally, viral studies on latex indicated that Mosi-guard Natural had antiviral activity against SARS-CoV-2 England-2 isolate," the UK report stated.

Back in May, UK Defense Secretary Ben Wallace confirmed that the British Armed Forces were using the insect repellant on a precautionary level as another potential layer of protection against the novel coronavirus, which was based on the advice of the UK surgeon general, who said it was unlikely to be harmful, according to an article in Science Focus.

“We are very excited by these findings and have several new studies either already going through laboratories or planned," Jacqueline Watson, managing director of Cetrifine, which produces Citriodiol, stated in a release on the company’s website.

The researchers stated in the report that “this research paper demonstrates preliminary findings on the effectiveness of Citriodiol against COVID-19.”

“Dstl is hopeful that the findings in this research can be used as a springboard for other organizations to expand and develop the research, as well as to confirm the findings in this publication," the study authors added.

Citriodiol is approved by the U.S. Environmental Protection Agency (EPA) and recommended by the U.S. Centers for Disease Control and Prevention (CDC) for use against mosquito bites, which can ultimately help to prevent the spread of mosquito-borne diseases.

Tags : #Citriodol #Antiviral #UKStudy #LatestCovidNewsUpdateAug29 #EPA #DSTL #CDC #BenWallace

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026